相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone
Hazel D. Brogdon et al.
JOURNAL OF ADDICTION MEDICINE (2022)
Long-term buprenorphine treatment for kratom use disorder: A case series
Viktoriya R. Broyan et al.
SUBSTANCE ABUSE (2022)
Pressure Necrosis Requiring Fasciotomy After Kratom Overdose
Natasha Tobarran et al.
JOURNAL OF ADDICTION MEDICINE (2022)
Kratom ( Mitragyna speciosa ) Validation: Quantitative Analysis of Indole and Oxindole Alkaloids Reveals Chemotypes of Plants and Products #
Preston K. Manwill et al.
PLANTA MEDICA (2022)
Understanding Kratom Use: A Guide for Healthcare Providers
Marc T. Swogger et al.
FRONTIERS IN PHARMACOLOGY (2022)
Clinical Pharmacokinetic Assessment of Kratom (Mitragyna speciosa), a Botanical Product with Opioid-like Effects, in Healthy Adult Participants
Rakshit S. Tanna et al.
PHARMACEUTICS (2022)
Kratom: Substance of Abuse or Therapeutic Plant?
David A. Gorelick
PSYCHIATRIC CLINICS OF NORTH AMERICA (2022)
Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross-sectional study
Jonathan Schimmel et al.
ADDICTION (2021)
Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations
Rakshit S. Tanna et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2021)
Modeling Pharmacokinetic Natural Product-Drug Interactions for Decision-Making: A NaPDI Center Recommended Approach
Emily J. Cox et al.
PHARMACOLOGICAL REVIEWS (2021)
Activity of Mitragyna speciosa (Kratom) Alkaloids at Serotonin Receptors
Francisco Leon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic
Albert Garcia-Romeu et al.
DRUG AND ALCOHOL DEPENDENCE (2020)
Investigation of the Adrenergic and Opioid Binding Affinities, Metabolic Stability, Plasma Protein Binding Properties, and Functional Effects of Selected lndole-Based Kratom Alkaloids
Samuel Obeng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids
Shyam H. Kamble et al.
TOXICOLOGY LETTERS (2020)
The Chemistry of Kratom [Mitragyna speciosa]: Updated Characterization Data and Methods to Elucidate Indole and Oxindole Alkaloids
Laura Flores-Bocanegra et al.
JOURNAL OF NATURAL PRODUCTS (2020)
Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions
D. A. Todd et al.
SCIENTIFIC REPORTS (2020)
The internet market for Kratom, an opioid alternative and variably legal recreational drug
Rebecca S. Williams et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2020)
Kratom exposures reported to United States poison control centers: 2011-2017
Sara Post et al.
CLINICAL TOXICOLOGY (2019)
Unintentional Drug Overdose Deaths with Kratom Detected-27 States, July 2016-December 2017
Emily O'Malley Olsen et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
u Kratom as a substitute for opioids: Results from an online survey
Marion A. Coe et al.
DRUG AND ALCOHOL DEPENDENCE (2019)
Characteristics of deaths associated with kratom use
John M. Corkery et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Deaths in Colorado Attributed to Kratom
Ken Gershman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Kratom from Head to Toe-Case Reviews of Adverse Events and Toxicities
Emad Alsarraf et al.
CURRENT EMERGENCY AND HOSPITAL MEDICINE REPORTS (2019)
Inhibition of UGT2B7 Enzyme Activity in Human and Rat Liver Microsomes by Herbal Constituents
Nurul Huda Abdullah et al.
MOLECULES (2018)
Rifampin modulation of xeno- and endobiotic conjugating enzyme mRNA expression and associated microRNAs in human hepatocytes
Brandon T. Gufford et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2018)
PXR mediated induction of CYP3A4, CYP1A2, and P-gp by Mitragyna speciosa and its alkaloids
Vamshi K. Manda et al.
PHYTOTHERAPY RESEARCH (2017)
Fluoxetine- and Norfluoxetine-Mediated Complex Drug-Drug Interactions: In Vitro to In Vivo Correlation of Effects on CYP2D6, CYP2C19, and CYP3A4
J. E. Sager et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Assessment of a Candidate Marker Constituent Predictive of a Dietary Substance-Drug Interaction: Case Study with Grapefruit Juice and CYP3A4 Drug Substrates
Garrett R. Ainslie et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Physicochemical Space for Optimum Oral Bioavailability: Contribution of Human Intestinal Absorption and First-Pass Elimination
Manthena V. S. Varma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Grapefruit Juice-Drug Interaction Studies as a Method to Assess the Extent of Intestinal Availability: Utility and Limitations
Michael Gertz et al.
CURRENT DRUG METABOLISM (2008)
Inhibitory effects of kratom leaf extract (Mitragyna speciosa Korth.) on the rat gastrointestinal tract
Somsmorn Chittrakarn et al.
JOURNAL OF ETHNOPHARMACOLOGY (2008)
Development of the Inje cocktail'' for high-throughput evaluation of five human cytochrome p450 Isoforms in vivo
J. Y. Ryu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Antinociceptive effect of 7-hydroxymitragynine in mice:: Discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa
K Matsumoto et al.
LIFE SCIENCES (2004)